MARK RITCHART is listed as an executive officer and director on 12 SEC Form D filings by 3 issuers between Sep 2010 and Oct 2026: AVENU MEDICAL, INC. (San Juan Capistrano, CA — other health care — 2010–2018; $13.1M reported sold to 77 investors), Ellipsys Medical, Inc. (San Clemente, CA — other health care — 2026; $8.57M reported sold to 91 investors) and Aveera Medical Inc. (San Clemente, CA — other technology — 2024–2026; $5.35M reported sold to 89 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 16 years. Across those companies the filings report $27M sold in total.
Listed alongside Steve Parker (11 shared filings), BRIAN DRISCOLL (6 shared filings), ED CHANG (6 shared filings), JEFFREY HULL (6 shared filings), EDDIE L. CHANG (5 shared filings) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around MARK. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 12 public filings for MARK RITCHART and found 5 differences: Form D filed 17 days after the first sale; Form D filed 40 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.